Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis.

PMID: J Adv Res. 2022 Jun 16. Epub 2022 Jun 16. PMID: 35718080 Abstract Title: Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR / EST pathway. Abstract:: Intro duction Chronic psychological stress is a well-established risk factor for breast cancer development. Si-Ni-San (SNS) is … Read more

Andrographolide exhibits anticancer activity against breast cancer cells MCF-7 and MDA-MB-231 cells.

PMID: Molecules. 2022 May 31; 27 (11). Epub 2022 May 31. PMID: 35684480 Abstract Title: Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K / AKT / mTOR Signaling. Abstract: Breast cancer is the most common cancer … Read more

An olive oil mill wastewater extract improves chemotherapeutic activity against breast cancer cells.

n / a PMID: Front Cardiovasc Med. 2022; 9: 867867. Epub 2022 Apr 14. PMID: 35498037 Abstract Title: An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity. Abstract: Cardiovascular toxicity in cancer patients receiving chemotherapy remains one of the most undesirable side effects, limiting the choice of … Read more

Screening of immune-related genes and predicting the immunotherapeutic effects of formononetin in breast cancer.

PMID: Evid Based Complement Alternat Med. 2022; 2022: 9942373. Epub 2022 Apr 15. PMID: 35463082 Abstract Title: Screening of Immune-Related Genes and Predicting the Immunotherapeutic Effects of Formononetin in Breast Cancer: A Bioinformatics Analysis. Abstract: Objective: Immunotherapy is a promising breast cancer treatment. Nonetheless, tumor heterogeneity and the interaction between immune cells in the tumor … Read more

Honokiol inhibits HIF-1α-mediated glycolysis to halt breast cancer growth.

PMID: Front Pharmacol. 2022; 13: 796763. Epub 2022 Mar 8. PMID: 35350760 Abstract Title: Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth. Abstract: Hypoxia-inducible factor-1α (HIF-1α) induces the expression of glycolysis-related genes, which plays a direct and key role in Warburg effect. In a recent study, honokiol (HNK) was identified as one of the … Read more